Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of QNCX will decline by -100.00% over the next 2 Weeks and hit $0.00 by Monday, February 23, 2026. In that time frame, QNCX's share price is expected to range between $0.00 and $0.26.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 23, 2026 | 0.00 | 0.00 | 0.26 |
| Feb 20, 2026 | 0.00 | 0.00 | 0.46 |
| Feb 19, 2026 | 0.00 | 0.00 | 0.27 |
| Feb 18, 2026 | 0.00 | 0.00 | 0.81 |
| Feb 17, 2026 | 0.00 | 0.00 | 0.86 |
| Feb 16, 2026 | 0.00 | 0.00 | 0.71 |
| Feb 13, 2026 | 0.00 | 0.00 | 0.85 |
| Feb 12, 2026 | 0.00 | 0.00 | 0.64 |
| Feb 11, 2026 | 0.00 | 0.13 | 1.13 |
| Feb 10, 2026 | 0.00 | 0.22 | 1.22 |
QNCX shares rose +305.92% in Tuesday, February 10, 2026's trading session, rising from a previous close of $0.13 to move at $0.53. The stock demonstrated notable intraday movement (see QNCX's key stats for a full breakdown), fluctuating between $0.25 and $0.65, a +165.15% trading range. While recent weeks have seen some volatility, QNCX has managed to secure a -83.41% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.48B shares changing hands, 1.48B more than the previous session. This amounted to $780.50M in total market activity.
Will QNCX Continue Its Downward Trend?
According to analyst ratings and projections for QNCX, Quince Therapeutics, Inc. shares are anticipated to decrease by -104.19%, potentially reaching $0.26 per share by February 23, 2026. Short-term technical indicators for QNCX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the QNCX stock forecast, now is not the best time to buy QNCX stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on QNCX covering social and institutional perspectives.
QNCX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into QNCX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 30.51% to 32.31%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 39.47%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.75%, maintains a neutral outlook for the long term. Insights into QNCX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Quince Therapeutics Short-Term Forecasts
QNCX Forecast For Next 5 Days
Our algorithm anticipates Quince Therapeutics (QNCX) stock could hit $0.00 by Feb 17, 2026. This represents a - rise from today's price, following a +15.93% change over the past five days.
QNCX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Quince Therapeutics, Inc. (QNCX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.01, which would mean a -98.10% decrease from the current price of $0.53. Projections for this period range from a high of $1.30 to a low of $0.00.
QNCX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Quince Therapeutics's price over the next three months point to a rise. QNCX stock is expected to peak at $14.88 on May 08, 2026 after potentially dipping to $3.19 on Feb 10, 2026. On average, QNCX is likely to trade around $9.39 in the coming 90 days.
Quince Therapeutics Stock Forecast 2025
Based on our predictive models, Quince Therapeutics (QNCX) is expected to trade between $2.81 and $25.45 throughout 2026. This would result in an average price of $10.59, potentially offering investors a +1,906.82% return from current levels.
Quince Therapeutics, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Quince Therapeutics, Inc. (QNCX) is positioned to show a strong performance in February 2026. The price is predicted to move between $3.19 and $11.44, settling at an average of $7.75. This could translate to a +1,368.64% gain.
March 2026
Based on current market signals, Quince Therapeutics, Inc. is projected to trend march 2026. We forecast a trading range from $9.60 to $11.85, with a likely average price of $10.92. Investors could expect a potential return of +1,969.36%.
April 2026
Our predictive algorithms indicate Quince Therapeutics, Inc. stock may see a shift in April 2026. The expected range spans $4.64–$11.41, with an average target of $7.88. This represents a positive outlook and a possible gain of +1,393.27%.
May 2026
Analyzing established trends, Quince Therapeutics, Inc. looks set to move in May 2026. Projections place the stock between $11.41 and $15.40, averaging around $13.25. This suggests a +2,410.90% gain from current levels.
June 2026
Market indicators suggest Quince Therapeutics, Inc. could experience notable changes during June 2026. Prices could fluctuate within $3.74 to $10.47, with a midpoint forecast of $8.45. The stock might deliver a +1,501.29% gain.
July 2026
Forecasting for July 2026, models estimate that Quince Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.81 and $17.44, averaging $12.77. This signals a positive trajectory with potential returns around +2,319.94%.
August 2026
According to our latest forecast models, Quince Therapeutics, Inc. (QNCX) is positioned to show a strong performance in August 2026. The price is predicted to move between $8.21 and $15.11, settling at an average of $11.93. This could translate to a +2,160.75% gain.
September 2026
Based on current market signals, Quince Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $3.71 to $10.56, with a likely average price of $6.76. Investors could expect a potential return of +1,181.03%.
October 2026
Our predictive algorithms indicate Quince Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $7.77–$12.62, with an average target of $9.76. This represents a positive outlook and a possible gain of +1,749.54%.
November 2026
Analyzing established trends, Quince Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $5.04 and $12.08, averaging around $7.50. This suggests a +1,321.26% gain from current levels.
December 2026
Market indicators suggest Quince Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $10.06 to $25.45, with a midpoint forecast of $18.13. The stock might deliver a +3,335.66% gain.
January 2027
Forecasting for January 2027, models estimate that Quince Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $4.17 and $21.32, averaging $13.50. This signals a positive trajectory with potential returns around +2,458.27%.
February 2027
According to our latest forecast models, Quince Therapeutics, Inc. (QNCX) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.84, settling at an average of $0.62. This could translate to a +17.49% gain.
QNCX's history of dividends and stock splits also plays a role in long-term investor confidence.